Skip to main content
NCBI home page
Gut logoLink to Gut
. 1994 Oct;35(10):1368–1371. doi: 10.1136/gut.35.10.1368

Dukes's classification: a valid prognostic indicator for gastric cancer.

Y Adachi 1, M Mori 1, Y Maehara 1, K Sugimachi 1
PMCID: PMC1375006  PMID: 7959188

Abstract

Dukes's classification for colorectal cancer is simple, and correlates well with survival. This study assessed whether the principles of Dukes's classification applied to gastric cancer resulted in the separation of prognostically useful groups. The cumulative survival curves determined by Dukes's, Astler-Coller's (another classification for colorectal cancer), and the Japanese classification for gastric cancer were evaluated using 476 curatively treated patients with gastric cancer. Of the three staging systems, both Dukes's and the Japanese classifications showed a step-wise relationship between the stage of the tumour and the survival of patients. The prognostic value of Dukes's classification was reinforced when Dukes's C cases were subdivided according to the number of positive nodes (1-6 v > or = 7) or the level of positive nodes (n1 v n2,n3) but not when the subdivision was made according to the depth of wall invasion. A modified Dukes's classification in which Dukes's cases are subdivided according to the number of metastatic nodes (Dukes's Ca = 1-6 nodes, Dukes's Cb > 6 nodes) could be both simply and accurately applied to gastric cancer.

Full text

PDF
1368

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. ASTLER V. B., COLLER F. A. The prognostic significance of direct extension of carcinoma of the colon and rectum. Ann Surg. 1954 Jun;139(6):846–852. doi: 10.1097/00000658-195406000-00015. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. Adachi Y., Kamakura T., Mori M., Baba H., Maehara Y., Sugimachi K. Prognostic significance of the number of positive lymph nodes in gastric carcinoma. Br J Surg. 1994 Mar;81(3):414–416. doi: 10.1002/bjs.1800810331. [DOI] [PubMed] [Google Scholar]
  3. Barth R. J., Jr, Danforth D. N., Jr, Venzon D. J., Straus K. L., d'Angelo T., Merino M. J., Gerber L. Level of axillary involvement by lymph node metastases from breast cancer is not an independent predictor of survival. Arch Surg. 1991 May;126(5):574–577. doi: 10.1001/archsurg.1991.01410290046010. [DOI] [PubMed] [Google Scholar]
  4. Carr D. T. Is staging of cancer of value? Cancer. 1983 Jun 15;51(12 Suppl):2503–2505. doi: 10.1002/1097-0142(19830615)51:12+<2503::aid-cncr2820511320>3.0.co;2-2. [DOI] [PubMed] [Google Scholar]
  5. Fisher E. R., Sass R., Palekar A., Fisher B., Wolmark N. Dukes' classification revisited. Findings from the National Surgical Adjuvant Breast and Bowel Projects (Protocol R-01). Cancer. 1989 Dec 1;64(11):2354–2360. doi: 10.1002/1097-0142(19891201)64:11<2354::aid-cncr2820641127>3.0.co;2-#. [DOI] [PubMed] [Google Scholar]
  6. Jaehne J., Meyer H. J., Maschek H., Geerlings H., Burns E., Pichlmayr R. Lymphadenectomy in gastric carcinoma. A prospective and prognostic study. Arch Surg. 1992 Mar;127(3):290–294. doi: 10.1001/archsurg.1992.01420030052010. [DOI] [PubMed] [Google Scholar]
  7. Maehara Y., Okuyama T., Moriguchi S., Orita H., Kusumoto H., Korenaga D., Sugimachi K. Prophylactic lymph node dissection in patients with advanced gastric cancer promotes increased survival time. Cancer. 1992 Jul 15;70(2):392–395. doi: 10.1002/1097-0142(19920715)70:2<392::aid-cncr2820700204>3.0.co;2-p. [DOI] [PubMed] [Google Scholar]
  8. Nio Y., Tsubono M., Kawabata K., Masai Y., Hayashi H., Meyer C., Inoue K., Tobe T. Comparison of survival curves of gastric cancer patients after surgery according to the UICC stage classification and the General Rules for Gastric Cancer Study by the Japanese Research Society for gastric cancer. Ann Surg. 1993 Jul;218(1):47–53. doi: 10.1097/00000658-199307000-00008. [DOI] [PMC free article] [PubMed] [Google Scholar]
  9. Okusa T., Nakane Y., Boku T., Takada H., Yamamura M., Hioki K., Yamamoto M. Quantitative analysis of nodal involvement with respect to survival rate after curative gastrectomy for carcinoma. Surg Gynecol Obstet. 1990 Jun;170(6):488–494. [PubMed] [Google Scholar]
  10. Shiu M. H., Perrotti M., Brennan M. F. Adenocarcinoma of the stomach: a multivariate analysis of clinical, pathologic and treatment factors. Hepatogastroenterology. 1989 Feb;36(1):7–12. [PubMed] [Google Scholar]

Articles from Gut are provided here courtesy of BMJ Publishing Group

RESOURCES